Related references
Note: Only part of the references are listed.Methylation of serum insulin-like growth factor-binding protein 7 promoter in hepatitis B virus-associated hepatocellular carcinoma
Feng Li et al.
GENES CHROMOSOMES & CANCER (2014)
Insulin signaling, resistance, and metabolic syndrome: insights from mouse models into disease mechanisms
Shaodong Guo
JOURNAL OF ENDOCRINOLOGY (2014)
Serum insulin-like, growth factor binding protein-related protein 1 (IGFBP-rP1) and endometrial cancer risk in Chinese women
Yan Zhan et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
被撤回的出版物: Insulin-like Growth Factor-binding Protein-7 (IGFBP7): A Promising Gene Therapeutic for Hepatocellular Carcinoma (HCC) (Retracted article. See vol. 31, pg. 599, 2023)
Dong Chen et al.
MOLECULAR THERAPY (2013)
Evaluation of IGFBP-7 DNA methylation changes and serum protein variation in Swedish subjects with and without type 2 diabetes
Harvest F. Gu et al.
CLINICAL EPIGENETICS (2013)
Low Expression of IGFBP7 is Associated with Poor Outcome of Pancreatic Ductal Adenocarcinoma
Wei An et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Increased risk of cancer in patients with type 2 diabetes mellitus: A retrospective cohort study in China
Pian-Hong Zhang et al.
BMC PUBLIC HEALTH (2012)
The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation
R. K. Simmons et al.
DIABETOLOGIA (2010)
The functional IGFBP7 promoter-418G>A polymorphism and risk of head and neck cancer
Yu-Jing Huang et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2010)
IGFBP7: an oncosuppressor gene in thyroid carcinogenesis
M. G. Vizioli et al.
ONCOGENE (2010)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
The metabolic syndrome: in need of a global mission statement
A. J. Cameron et al.
DIABETIC MEDICINE (2009)
Type 2 diabetes mellitus associated with increased risk for colorectal cancer: Evidence from an international ecological study and population-based risk analysis in China
X. Ren et al.
PUBLIC HEALTH (2009)
Tumor suppressor gene insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) induces senescence-like growth arrest in colorectal cancer cells
Yu Ma et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2008)
Circulating IGF-binding protein 7 (IGFBP7) levels are elevated in patients with endometriosis or undergoing diabetic hemodialysis
Masahiko Kutsukake et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2008)
Insulin-like Growth Factor Binding Protein 7 Mediates Glioma Cell Growth and Migration
Wei Jiang et al.
NEOPLASIA (2008)
The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: The San Antonio heart study
Kelly J. Hunt et al.
ANNALS OF EPIDEMIOLOGY (2007)
Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1/MAC25) is linked to endothelial-dependent vasodilation in high-ferritin type 2 diabetes
Abel Lopez-Bermejo et al.
DIABETES CARE (2007)
IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis
Wenjing Ruan et al.
CANCER BIOLOGY & THERAPY (2007)
Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25)
Abel Lopez-Bermejo et al.
DIABETES (2006)
Characterization of mosaic supernumerary ring chromosomes by array-CGH:: Segmental aneusomy for proximal 4q in a child with tall stature and obesity
C Bonnet et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2006)
Detection of the differentially expressed gene IGF-binding protein-related protein-1 and analysis of its relationship to fasting glucose in Chinese colorectal cancer patients
L Shao et al.
ENDOCRINE-RELATED CANCER (2004)
Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults
S Malik et al.
CIRCULATION (2004)
Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer
XF Wu et al.
CLINICAL CANCER RESEARCH (2004)
Association between insulin-like growth factor-I : insulin-like growth factor-binding protein-1 ratio and metabolic and anthropometric factors in men and women
MS Sandhu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2004)
The impact of abnormalities in IGF and inflammatory systems on the metabolic syndrome
K Kaushal et al.
DIABETES CARE (2004)
Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam
BEK Klein et al.
DIABETES CARE (2002)
Insulin resistance: definition and consequences
HE Lebovitz
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2001)
Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance
PA Crossey et al.
DIABETES (2000)
Share Paper
